Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced Xerostomia
Launched by M.D. ANDERSON CANCER CENTER · Mar 16, 2009
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
Acupuncture is the use of very thin needles that are stuck in your skin at certain areas of the body, acupuncture is believed to affect bodily function.
Screening Tests:
Signing this consent form does not mean that you will be able to take part in this study. You will have "screening tests" to help the doctor decide if you are eligible to take part in this study. The following tests and procedures will be performed:
* Your complete medical history will be recorded.
* You will have a physical exam.
* You will complete 3 short questionnaires about your quality-of-life and current saliva fl...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:1) Adult \>/= 18 year of age and able to sign informed consent
- • 2) Diagnosed with nasopharyngeal carcinoma and scheduled to undergo IMRT
- • 3) Treatment plan must include treatment at a mean dose of 25 gray or more bilateral to the parotid
- • 4) Must have anatomically intact parotid and submandibular glands
- • 5) Karnofsky Performance Status \> 60
- • 6) If the participant is female and of child bearing potential, must have a negative urine pregnancy test. (Acupuncture should be used cautiously during pregnancy since some points have been shown to stimulate uterine contractions
- Exclusion Criteria:
- • 1. History of xerostomia prior to the head and neck radiation therapy (Sjögren's disease or other underlying systemic illness known to cause xerostomia).
- • 2. Prior head and neck radiation treatment
- • 3. Suspected or confirmed physical closure of salivary gland ducts on either side
- • 4. Known bleeding disorders or on Heparin or Coumadin
- • 5. Upper or lower extremity deformities that could interfere with accurate acupoint location or alter the energy pathway as defined by traditional acupuncture theory
- • 6. Local skin infections at or near the acupuncture site or active systemic infection
- • 7. History of cerebrovascular accident or spinal cord injury. (The mechanism of action for acupuncture may be associated with central nervous system (CNS) activity, and patients with CNS pathology may respond differently to treatment than the general population.)
- • 8. Mental incapacitation or significant emotional or psychiatric disorder that, in the opinion of the investigator, precludes study entry as these patients may not be able to cooperate with this slightly invasive procedure or with the data collection process
- • 9. Current acknowledged use of any illicit drugs or evidence of alcohol abuse as defined by The American Psychiatric Association criteria
- • 10. Participants who are taking or who have taken any investigational new drug within the last 30 days, or who are planning to take such a drug during the course of the study
- • 11. Current acknowledged use of other alternative medicines such as herbal preparations that could affect salivary function. Each patient will be asked for a list of herbal supplements they are currently taking and this will be reviewed on an individual basis. Patients will be excluded if they are taking any herbs known or suspected to affect salivary function
- • 12. Participants taking amifostine, cholinergic agonist medication (Pilocarpine, Cevimeline), beta adrenergic antagonists, anticholinergic agents, saliva substitutes or other medications known to affect salivary function
- • 13. Currently receiving acupuncture for any condition
- • 14. Prior use of acupuncture
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Joseph S. Chiang, MD, MS, BS
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials